Information:
Fel:
ID
34405
Beskrivning
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00941720
Länk
https://clinicaltrials.gov/show/NCT00941720
Nyckelord
Versioner (1)
- 2019-01-17 2019-01-17 -
Rättsinnehavare
GSK group of companies
Uppladdad den
17 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
patients with a diagnosis of plasma cell myeloma
boolean
ID.2
Item
patients with cardiac ejection fraction >= 45% or clearance by cleveland clinic faculty (ccf) cardiologist
boolean
ID.3
Item
patients with diffusion capacity of carbon monoxide (dlco) >= 45% predicted or clearance by ccf pulmonologist
boolean
ID.4
Item
patient with previously harvested peripheral blood progenitor cells with a minimum of 2 x 10^6 cd 34+ cells/kg harvested
boolean
ID.5
Item
patients receiving total body irradiation
boolean
ID.6
Item
non-myeloablative/reduced-intensity conditioning
boolean
ID.7
Item
pregnant and breast feeding patients
boolean
ID.8
Item
human immunodeficiency virus (hiv) positive
boolean
ID.9
Item
patients with serum creatinine > 2.0
boolean
ID.10
Item
prior hematopoietic stem cell (hsc) transplant
boolean